Novartis markets and sells a combination therapy of valsartan and sacubitril under the brand name Entresto® for the treatment of various forms ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...

Beginning in 2018, more than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan ... Prices for brand-name drugs are less likely to increase due to the trade ...

Beginning in 2018, more than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan ... Prices for brand-name drugs are less likely to increase due to the trade ...